📖
Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia.
Reijman MD, Nigmann C, Kusters DM, Planken RN, Loewe C, Verpalen VA, Hovingh GK, Neyer M, Draxler-Dworzak S, Mair K, Arbeiter K, Mueller-Sacherer T, Groothoff JW, Hutten BA, Greber-Platzer S, Wiegman A

Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in J Am Heart Assoc.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia.
Author / Organization Reijman MD, Nigmann C, Kusters DM, Planken RN, Loewe C, Verpalen VA, Hovingh GK, Neyer M, Draxler-Dworzak S, Mair K, Arbeiter K, Mueller-Sacherer T, Groothoff JW, Hutten BA, Greber-Platzer S, Wiegman A
Subject & Discipline J Am Heart Assoc
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6159
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »